-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Minimed Group, Lowers Price Target to $20

Benzinga·05/18/2026 17:54:37
Listen to the news
B of A Securities analyst Travis Steed maintains Minimed Group (NASDAQ:MMED) with a Buy and lowers the price target from $27 to $20.